Fig. 2From: Sodium-glucose co-transporter 2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: an updated systematic review and meta-analysisForest plot for the effect of SGLT2 inhibitors vs placebo on the risk of outcomes for patients with HFmrEF/HFpEF. Forest plot reporting the hazard ratios of the SGLT2 inhibitors vs placebo in patients with HFmrEF/HFpEF: A cardiovascular death or hospitalization for heart failure; B Cardiovascular death; C heart failure hospitalization; D All-cause deathBack to article page